Thought Leadership

Latest Report

Thumbnail

Evaluate Vantage Biopharma and Venture Capital: A Deep Dive

The sheer amount of private capital available to young drug developers the last few years is nothing new, however the Covid-19 pandemic has brought about an unprecedented influx of new money into biopharma. How permanent will these new funds prove; is biopharma's importance and attributes finally being realised by investors, governments and…

Report library

Thumbnail

Evaluate Vantage 2021 Preview

Biopharma’s role in trying to bring the COVID-19 pandemic to an end has made household names of companies large and small, and cutting-edge technologies like mRNA…